CEO Vas Narasimhan of Swiss drugmaker Novartis addresses the company’s

March 17, 2025

CEO Vas Narasimhan of Swiss drugmaker Novartis addresses the company’s annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann